Trademark: 88768179
Status Date
Tuesday, April 20, 2021
Registration Number
6325211
Registration Date
Tuesday, April 20, 2021
Filing Date
Tuesday, January 21, 2020
Published for Opposition
Tuesday, February 2, 2021
1 Biological preparations in the nature of eukaryotic cells, isogenic cell lines and bio-production cell lines generated using base editing engineering for scientific, laboratory or medical research; reagents, plasmids and assays for scientific, genetic and medical research; genomic reference control samples for medical laboratory use; molecular biology research tools, in the nature of chemical, biological and biochemical reagents; biological preparations in the nature of separate base editing components including mRNA, rRNA, gRNA, deaminase, nickase, ribonucleotide protein (RNP) for use in scientific, laboratory or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and industrial use
5 Diagnostic preparations and materials generated by the use of base editing components for medical purposes; chemical preparation for use in DNA analysis for medical purposes; biological preparations in the nature of DNA, RNA and parts thereof for medical purposes; biological preparations in the nature of DNA extracts for medical purposes; biological preparations in the nature of gene editing enzymes for medical purposes; biological preparations in the nature of protein cell lysates, genomic DNA preparations and Formalin Fixed, Paraffin Embedded (FFPE) engineered tumour tissue mimics for medical diagnostic use; biological preparations in the nature of biological, biochemical and chemical reagents, including living cells, genetically modified cells and vectors, genomic DNA, cell cultures and mutant and normal isogenic cell line pairs, peptides, proteins and nucleic acids or complexes of these molecules for medical use; all the aforesaid goods being medical preparations
9 collections of DNA and gene sequences for research and reference purposes provided as DNA microarrays and DNA chips
40 Treatment of biopharmaceutical materials; custom manufacture of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies; consultancy and advisory services relating to the aforesaid services
42 Custom cell-line engineering services; gene base-editing services for research purposes; gene engineering services; research and development services in the creation of databases or collections of information on biologicals including cells and cell lines for research purposes; creating and providing databases or collections of information on normal and mutated genes for research purposes; providing DNA reference standards for research purposes; providing DNA reference databases being collections of DNA and gene sequences for research purposes; research on cell line models; contract research on cell line models; research and development services relating to targeting therapies to individuals; establishing patient genotypes for research or analysis purposes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling for research purposes; design of clinical trials for research purposes; research and development in re-positioning existing drugs from other therapeutic indications; consultancy and advisory services relating to the aforesaid services; all of the aforesaid services relating to biological and medical research and research and development in the field of cells and cell therapies, genome editing, genetic engineering and gene therapies
Apr 20, 2021
Registered-Principal Register
Feb 2, 2021
Official Gazette Publication Confirmation E-Mailed
Feb 2, 2021
Published For Opposition
Jan 13, 2021
Notification Of Notice Of Publication E-Mailed
Dec 28, 2020
Approved For Pub - Principal Register
Dec 26, 2020
Teas/Email Correspondence Entered
Dec 26, 2020
Correspondence Received In Law Office
Dec 26, 2020
Teas Response To Office Action Received
Sep 29, 2020
Notification Of Non-Final Action E-Mailed
Sep 29, 2020
Non-Final Action E-Mailed
Sep 29, 2020
Non-Final Action Written
Sep 28, 2020
Teas/Email Correspondence Entered
Sep 26, 2020
Correspondence Received In Law Office
Sep 26, 2020
Teas Response To Office Action Received
Jun 4, 2020
Teas Change Of Correspondence Received
Jun 4, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 4, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 9, 2020
Notification Of Non-Final Action E-Mailed
Apr 9, 2020
Non-Final Action E-Mailed
Apr 9, 2020
Non-Final Action Written
Apr 8, 2020
Assigned To Examiner
Mar 30, 2020
Preliminary/Voluntary Amendment - Entered
Mar 26, 2020
Assigned To Lie
Mar 20, 2020
Teas Voluntary Amendment Received
Jan 25, 2020
New Application Office Supplied Data Entered In Tram
Jan 24, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
